Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer

Overview of attention for article published in Frontiers in Nuclear Medicine, September 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,761 followers.

RT @FrontNuclearMed: New Research: Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate…

21 Sep 2023

Reply Repost Favourite

RT @FrontNuclearMed: New Research: Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate…

20 Sep 2023

Reply Repost Favourite

New Research: Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer #NuclearMedicine https://t.co/y539cjmVPd

20 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.